• Info
  • Insider Ownership

Insider Trading & Ownership of Julie Gerberding

Location
Boston, MA
Summary
The estimated net worth of Julie Gerberding is at least $5,918,502 dollars as of 17 Sep 2025. Julie Gerberding is the EVP, Chief Patient Officer of Merck & Co., Inc. and owns shares of Merck & Co., Inc. (MRK) stock worth about $5.82M. Julie Gerberding is the Director of MCKESSON CORP and owns shares of MCKESSON CORP (MCK) stock worth about $100.8K.
Signature
/s/ Paul Bavier, Attorney-in-Fact for Julie Gerberding
All Insider Reports
All Insider Reports

Notify me when Julie Gerberding files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Julie Gerberding

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
MRK Merck & Co., Inc. EVP, Chief Patient Officer $5,817,691 24 Feb 2022
MCK MCKESSON CORP Director $100,811 30 Jul 2025
HLVX HilleVax, Inc. Director $0 17 Sep 2025
AFTR AfterNext HealthTech Acquisition Corp. Director 11 Aug 2021
CERN CERNER Corp Director 07 Jun 2022

Insider Transactions Reported by Julie Gerberding:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.